To hear about similar clinical trials, please enter your email below
Trial Title:
Raman Spectroscopic Analysis of Bronchoscopic Biopsy for Diagnosing Lung Cancer
NCT ID:
NCT05799027
Condition:
Lung Cancer
Conditions: Official terms:
Lung Neoplasms
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Diagnostic
Masking:
None (Open Label)
Intervention:
Intervention type:
Diagnostic Test
Intervention name:
Raman spectrum
Description:
The bronchoscopic biopsy sample of patients with visible lesions in the airway would
undergo raman spectrum analysis.
Arm group label:
Raman spectrum analysis
Summary:
The goal of this clinical trial is to evaluate raman spectroscopic analysis of
bronchoscopic biopsy for diagnosing lung cancer in visible lesions in the airway. The
main question it aims to answer are: the diagnostic efficacy raman spectroscopic analysis
of bronchoscopic biopsy for diagnosing lung cancer.
The bronchoscopic biopsy sample of patients with visible lesions in the airway would
undergo raman spectrum analysis.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Patients who plan to undergo bronchoscopic biopsy or EBUS-TBNA
- Visible intratracheal lesions under bronchoscope
- Non-visible lesions suspected of lung cancer
Exclusion Criteria:
- The patient could not tolerate further examination aimed at clarifying the cause of
the disease or refused to accept further examination aimed at clarifying the cause
of the disease due to poor general condition, serious organ dysfunction, etc
- The patient has no definite diagnosis
Gender:
All
Minimum age:
18 Years
Maximum age:
90 Years
Healthy volunteers:
No
Start date:
March 31, 2023
Completion date:
December 31, 2024
Lead sponsor:
Agency:
China-Japan Friendship Hospital
Agency class:
Other
Source:
China-Japan Friendship Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05799027
